Understanding DTx

DTA Resources

Essential content for patients and caregivers, clinicians, policymakers, and healthcare decision makers to meaningfully integrate DTx products into practice and transform global healthcare.

Featured Resources

Policymaker & Payor DTx Evaluation Toolkit

DTA developed this Toolkit to provide a common language and process for HCDMs and DTx manufacturers to jointly use throughout DTx product evaluation and implementation processes.

Policymaker & Payor DTx Evaluation Toolkit

DTx Regulatory and Reimbursement Pathways

Country-specific pathway overviews to help policymakers and DTx manufacturers understand how DTx products are recognized, regulated, and funded.

DTx by Country

DTx Product Library

Repository of DTx products that are available to patients on the market, meet the definition of a DTx product, and attest to aligning with industry Core Principles.

Product Library

Additional Resources

Region-specific Efforts

Europe DTx Policy Coalition
DTx Policy Pathways: The Evolving Scenario in Europe
Country-specific regulatory and reimbursement overviews:
- Australia
- China
- France
- Germany
- Japan
- South Korea
- United Kingdom
- United States

Patient & Clinician Adoption

DTx Commercialization

DTx Product Benchmark Questions (2022)
Implementing Digital Therapeutics in Practice (2022)
Setting the Stage for a Fit-For-Purpose DTx Evidentiary Standard (2022)
United States DTx Workflow & Integration
- Progress Report (2023)
- Rx DTx Compendia Submission & Tracking (2023)
DTx Market and Patient Access Pathways (2023)
DTx Prescription vs. Non-Prescription Pathways (2023)
DTx Commercialization Launch Playbook Case Study (2023)

DTA Resources

Featured Resources

Policymaker & Payor DTx Evaluation Toolkit

DTx Regulatory and Reimbursement Pathways

DTx Product Library

Additional Resources

Region-specific Efforts

Patient & Clinician Adoption

DTx Commercialization

Policy & Legislation

DTx Industry Foundations

Frequent Questions

Join the DTA Community